Ligand Pharma (LGND) PT Lowered to $135 at H.C. Wainwright

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. SPY
10. FISV

Go back to Ligand Pharma (LGND) PT Lowered to $135 at H.C. Wainwright

Ligand Pharma (LGND) PT Lowered to $150 at Barclays

October 25, 2022 5:54 AM EDT

Barclays analyst Balaji Prasad lowered the price target on Ligand Pharma (NASDAQ: LGND) to $150.00 (from $157.00) while maintaining a Overweight rating.... More

OmniAb Business Combination Approved by APAC Shareholders (AHPA)

October 24, 2022 5:04 PM EDT

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced the business combination (Business Combination) of Avista Public Acquisition Corp. II (APAC) (NASDAQ: AHPA) and OmniAb, Inc. (OmniAb), was approved by APAC shareholders in a vote held this morning, with 96% of the shares represented in person, virtually or by proxy voting in favor of the combination. Based on actual redemptions and estimated expenses, OmniAb expects to have approximately $95 million of net cash upon the closing of the Business Combination (Closing). Prior to the Business Combination, APAC will domesticate in... More